Loperamide: Difference between revisions
3amrbadawy (talk | contribs) (lop ref) |
3amrbadawy (talk | contribs) (lop admin) |
||
| Line 1: | Line 1: | ||
==Administration== | ==Administration== | ||
*Type: | *Type: Anti-diarrheal, opioid | ||
*Dosage Forms: | *Dosage Forms: 1mg, 2mg; 1/5 mL | ||
*Routes of Administration: | *Routes of Administration: PO | ||
*Common Trade Names: Imodium | *Common Trade Names: Imodium, Diamode, Imodium A-D, Imodium A-D EZ Chews, Imodium A-D New Formula, Kao-Paverin, Kaopectate 1-D | ||
==Adult Dosing== | ==Adult Dosing== | ||
Revision as of 19:30, 25 January 2016
Administration
- Type: Anti-diarrheal, opioid
- Dosage Forms: 1mg, 2mg; 1/5 mL
- Routes of Administration: PO
- Common Trade Names: Imodium, Diamode, Imodium A-D, Imodium A-D EZ Chews, Imodium A-D New Formula, Kao-Paverin, Kaopectate 1-D
Adult Dosing
- Acute Diarrhea:
- 2 mg PO per dose
- Start: 4 mg PO x1, then 2 mg PO after each loose stool; Max: 16 mg/day
- 2 mg PO per dose
- Chronic Diarrhea
- 4-8 mg/day PO divided qd-tid
- Start: 4 mg PO x1, then 2 mg PO after each loose stool until maint. dose established; Max: 16 mg/day
- 4-8 mg/day PO divided qd-tid
Pediatric Dosing
- Acute diarrhea:
- 2-5 yo, 13-20 kg
- Dose: 1 mg PO x1 after each loose stool
- Max: 3 mg/day
- Use OTC 1 mg/5 sol or 1 mg/7.5 mL susp
- Dose: 1 mg PO x1 after each loose stool
- 6-8 yo, 20-30 kg
- Dose: start 2 mg PO x1, then 1 mg PO after each loose stool
- Max: 4 mg/day
- Dose: start 2 mg PO x1, then 1 mg PO after each loose stool
- 8-11 yo, 30-40 kg
- Dose: start 2 mg PO x1, then 1 mg PO after each loose stool
- Max: 6 mg/day
- Dose: start 2 mg PO x1, then 1 mg PO after each loose stool
- 12 yo and older
- Dose: start 4 mg PO x1, then 2 mg PO after each loose stool
- Max: 8 mg/day
- Dose: start 4 mg PO x1, then 2 mg PO after each loose stool
- 2-5 yo, 13-20 kg
- Chronic diarrhea
- 0.08-0.24 mg/kg/day PO divided bid-tid
- Max: 2 mg/dose
- 0.08-0.24 mg/kg/day PO divided bid-tid
Special Populations
- Pregnancy Rating: B
- Lactation risk: Probably safe
Renal Dosing
- Adult:
Hepatic Dosing
- Adult/Pediatric: Reduced first-pass metabolism
- CNS toxicity
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- toxic megacolon
- paralytic ileus
- angioedema
- anaphylaxis/anaphylactoid rxn
- toxic epidermal necrolysis
- Stevens-Johnson syndrome
- erythema multiforme
- urinary retention
- heat stroke
Common
- constipation
- nausea
- abdominal cramps
- dizziness
Pharmacology
- Half-life: Half-life: 10.8h
- Metabolism: liver; CYP450: 2C8, 3A4 substrate; Info: P-gp substrate; 40% systemic absorption
- Excretion: feces 30%, urine <2%
Mechanism of Action
binds gut wall opioid receptor, inhibiting peristalsis; increases anal sphinctor tone
